Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has announced that it expects to surpass its upgraded FY24 revenue forecast of $12.5 million, marking a second consecutive ...

Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant ...

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of A$0.85. The company’s shares opened today at A$0.62. See what ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and ...